Manya Mboni Henry, Faes Marie, Fraselle Stéphanie, Compaoré Moussa, Salvius Bakari Amuri, Joseph Kahumba Byanga, Duez Pierre, Jean-Baptiste Lumbu Simbi, Stévigny Caroline
Laboratoire de Pharmacognosie, Faculté des Sciences Pharmaceutiques, Université de Lubumbashi, BP.1825, Lubumbashi, Democratic Republic of the Congo.
Unité de Pharmacognosie, Bioanalyse et Médicaments, Faculté de Pharmacie, Université Libre de Bruxelles (ULB), Campus de la Plaine - CP205/9, Boulevard du Triomphe, B-1050, Bruxelles, Belgium.
Heliyon. 2023 Sep 13;9(9):e20103. doi: 10.1016/j.heliyon.2023.e20103. eCollection 2023 Sep.
, , and are used against malaria in traditional medicine in the Democratic Republic of the Congo (DRC). To evaluate their potential in the treatment of this disease, the antiplasmodial property of these four plants was evaluated. All experiments were conducted on methanolic extracts performed on selected organ parts of these plants.
The methanolic extracts, obtained by maceration, were firstly screened against the chloroquine sensitive (3D7) and resistant (W2) strains by the measurement of lactate dehydrogenase activity, and on human keratinocytes (HaCat) cells by the MTT assay to determine their selectivity indices (SI). Secondly, the antioxidant activity of the same extracts was evaluated using DPPH and FRAP assays. Finally, the presence of specific phytochemical constituents was evaluated using standard methods and tentatively identified by GC-MS.
An optimum antiplasmodial activity (IC = 3.4 ± 0.7 μg/mL, for 3D7, SI = 58.2; IC = 7 ± 1.0 μg/mL, for W2, SI = 28.3) was obtained with the leave extract of . The leaves (for and ), and the aerial part (for ) extracts showed promising and moderate antiplasmodial activities against respectively the 3D7 strain (IC: <15 μg/mL), and W2 strain (IC:15-50 μg/mL). All extracts presented a weak cytotoxic effect (IC: >100 μg/mL) on HaCat cells. For the antioxidant test, the most interesting activity was obtained with the leaf extract of . The GC-MS analysis of these four plants species extracts revealed the presence of various compounds, such as Ethyl 2-nonenoate, 2-(2-Hydroxy-2-phenylethyl)-3,5,6-trimethyl pyrazine, Palmitic Acid, Ethyl palmitate, Ethyl linolenate, and N-Acetyltyramine.
Based on the obtained results, could be selected for further investigations or ⁄and for the management of malaria after standardization.
在刚果民主共和国的传统医学中,[植物名称1]、[植物名称2]、[植物名称3]和[植物名称4]被用于抗疟疾治疗。为评估它们治疗该疾病的潜力,对这四种植物的抗疟原虫特性进行了评估。所有实验均针对这些植物选定器官部位的甲醇提取物开展。
通过浸渍法获得的甲醇提取物,首先通过测量乳酸脱氢酶活性针对氯喹敏感(3D7)和耐药(W2)菌株进行筛选,并通过MTT法在人角质形成细胞(HaCat)上进行测定以确定其选择性指数(SI)。其次,使用DPPH和FRAP测定法评估相同提取物的抗氧化活性。最后,使用标准方法评估特定植物化学成分的存在情况,并通过气相色谱 - 质谱联用(GC - MS)进行初步鉴定。
[植物名称1]叶提取物获得了最佳抗疟原虫活性(对3D7,IC₅₀ = 3.4 ± 0.7 μg/mL,SI = 58.2;对W2,IC₅₀ = 7 ± 1.0 μg/mL,SI = 28.3)。[植物名称2]和[植物名称3]的叶提取物以及[植物名称4]的地上部分提取物分别对3D7菌株(IC₅₀:<15 μg/mL)和W2菌株(IC₅₀:15 - 五十 μg/mL)显示出有前景的中等抗疟原虫活性。所有提取物对HaCat细胞均呈现出较弱的细胞毒性作用(IC₅₀:>100 μg/mL)。对于抗氧化测试,[植物名称1]叶提取物获得了最显著的活性。对这四种植物提取物的GC - MS分析揭示了各种化合物的存在,如2 - 壬烯酸乙酯、2 - (2 - 羟基 - 2 - 苯乙基)- 3,5,6 - 三甲基吡嗪、棕榈酸、棕榈酸乙酯、亚麻酸乙酯和N - 乙酰酪胺。
基于所得结果,[植物名称1]可被选择用于进一步研究和/或标准化后用于疟疾的治疗。